Neuphoria Therapeutics Inc. financial data

Symbol
NEUP on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Summit Dr, Burlington, MA
State of incorporation
Australia
Fiscal year end
June 30
Former names
BIONOMICS LIMITED/FI (to 12/23/2024)
Latest financial report
10-Q - Q4 2024 - Feb 14, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.76M shares
Common Stock, Shares, Outstanding 1.63M shares
Entity Public Float 13.3M USD
Common Stock, Value, Issued 16 USD
Weighted Average Number of Shares Outstanding, Basic 1.58B shares
Weighted Average Number of Shares Outstanding, Diluted 1.58B shares

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 663K USD
Research and Development Expense 1.74M USD -14.6%
General and Administrative Expense 2.63M USD +4.42%
Operating Income (Loss) -3.7M USD +18.7%
Nonoperating Income (Expense) 1.77M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.93M USD +57.9%
Income Tax Expense (Benefit) 11.6K USD
Net Income (Loss) Attributable to Parent -1.94M USD +57.3%
Earnings Per Share, Basic -1.23 USD/shares +76.8%
Earnings Per Share, Diluted -1.23 USD/shares +76.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 4.34M USD -57.2%
Accounts Receivable, after Allowance for Credit Loss, Current 35.6K USD
Assets, Current 4.4M USD
Property, Plant and Equipment, Net 1.68K USD
Operating Lease, Right-of-Use Asset 151K USD
Intangible Assets, Net (Excluding Goodwill) 5.14M USD
Goodwill 8.41M USD -4.9%
Assets 18.2M USD
Accounts Payable, Current 1.53M USD
Liabilities, Current 2.13M USD
Deferred Income Tax Liabilities, Net 843K USD
Operating Lease, Liability, Noncurrent 49.8K USD
Other Liabilities, Noncurrent 3.39K USD
Liabilities 4.42M USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -3.72M USD
Retained Earnings (Accumulated Deficit) -181M USD
Stockholders' Equity Attributable to Parent 13.7M USD -29.5%
Liabilities and Equity 18.2M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -4.43M USD -0.07%
Net Cash Provided by (Used in) Financing Activities -227K USD -137%
Common Stock, Shares Authorized 30M shares
Common Stock, Shares, Issued 1.63M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 4.42M USD -56.8%
Deferred Tax Assets, Gross 28.5M USD +18.3%
Operating Lease, Liability 168K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.23M USD +21.2%
Lessee, Operating Lease, Liability, to be Paid 174K USD
Property, Plant and Equipment, Gross 47.7K USD -0.09%
Operating Lease, Liability, Current 118K USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 183K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 114K USD
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.49K USD
Preferred Stock, Shares Authorized 3M shares
Additional Paid in Capital 198M USD
Deferred Tax Assets, Net of Valuation Allowance 27.7M USD +18%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares